This is a program of the U.S. Department of Health and Human Services, Office of Public Health Emergency Medical Countermeasures, and the National Institutes of Health. The program is coordinated by NIAID, with the involvement of the National Cancer Institute.
The Centers for Medical Countermeasures against Radiation Consortium (CMCRC) Pilot Project Opportunity: Accepting letters of intent for pilot projects focused on practical approaches for radiation biodosimetry or development of mitigators of acute or late radiation effects. Letters of intent due Oct, 9, 2015; full applications due Nov. 23, 2015.
NIAID Radiation and Nuclear Countermeasures Program (RNCP) gets approval for new Research Initiative Concepts at May 2015 Council Meeting.
NSBRI Research and Technology Development to Support Crew Health and Performance in Space Exploration Missions: “Protect Healthy-Tissues from Ionizing Radiation by Accelerating the Testing of Potential Countermeasures in Human Clinical Research Trials”. Step 1 Proposal due Sept. 4, 2015.
PHS2016-1: NIH/NCI SBIR Topic 345: Predictive Biomarkers of Adverse Reactions to Radiation Treatment. Due Date – Oct. 16, 2015.
PHS2016-1: NIH/NCI SBIR Topic 346: Molecularly Targeted Radiation Therapy For Cancer Treatment Due Date – Oct. 16, 2015.
FDA approves Neupogen® for treatment of patients with radiation-induced myelosuppression following a radiological/nuclear incident
NOT-OD-15-156: ASSIST Now an Option for Small Business Grant Applications. ASSIST is NIH's on-line system for the preparation, submission and tracking of grant applications through Grants.gov to NIH
All Radiological and Nuclear Threats News Releases
News From NIAID-Supported Institutions
Last Updated September 28, 2015